Tess Cameron

Jan 4, 2024 | rapport.bio | Peter Kolchinsky |Tess Cameron

January 4, 2024With an insane amount of data analysis and insights by Alex Martinez-Forte, Jacqueline Rhuda, and Kris Shuman, and a massive graphics effort by Erin Clutter. * * *A year ago we published the first “Semper Maior” piece, making the case that biotech was on firm ground and ready for a reboot. We put out the second piece last summer, when it felt like the rebound was underway. Had the year ended in October or even November… well, you know.

Mar 12, 2023 | rapport.bio | Peter Kolchinsky |Josh Resnick |Tess Cameron |Kyle Teamey

By Kyle Teamey, Josh Resnick, Tess Cameron, and Peter KolchinskyKyle Teamey is Managing Partner, Planetary Health, at RA Capital Management. Josh Resnick is Managing Director at RA Capital Management. Tess Cameron is Principal, Strategic Finance, at RA Capital Management. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal.